Agenus is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Garo H. Armen, with a market cap of $130.2M.
Common questions about Agenus
Agenus is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $129.5M.
Agenus has approximately 389 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.